“Spain is a pioneer country in the development of biotechnology startups and companies like Neuro-Bio”

Neuro-Bio is a biotechnology company from the UK that develops treatments for Alzheimer’s disease (AD). The company is now looking to attract up to 10 million pounds sterling in stages to advance in the clinical development of its new molecule, NBP 14. With these resources the company, whose headquarters are in Abindgon, Oxfordshire, will fund […]